• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Readout Health wins JDRF grant to evaluate handheld breath ketone monitor

July 12, 2022 By Sean Whooley

Readout Health Biosense Device health app
[Image from Readout Health]
Readout Health announced today that it entered into a sponsored research agreement with Washington University School of Medicine.

The agreement with Washington University School of Medicine (St. Louis) includes a two-year, $360,000 research grant from JDRF to test the efficacy of the Biosense handheld breath ketone monitor in persons with type 1 diabetes during usual care with insulin and with the addition of a sodium-glucose transporter inhibitor (SGLT2i) drug.

According to a news release, Dr. Janet McGill, a Washington University School of Medicine professor and recipient of the American Diabetes Association’s 2022 Outstanding Physician Clinician award, will serve as the principal investigator.

Readout Health launched Biosense in 2020 as a non-invasive option to capillary blood testing or urine testing for in-home biofeedback of fat oxidation levels based on nutrition and exercise. The company said that type 1 diabetes patients can be considered to be at considerable risk with elevated ketones, a problem potentially compounded by medications like SGLT2i if left unchecked.

“Routine monitoring of ketones may alert patients to impeding ketosis and help to prevent episodes of ketoacidosis,” McGill said in the release. “Ketone monitoring should be easy, non-invasive, low-cost, and accessible for repeated use to be effective.”

Biosense will be tested for its ability to detect ketosis in persons with type 1 diabetes during usual care and during usual care plus SGLTi therapy with the ultimate goal of reducing the risk of diabetic ketoacidosis (DKA). The first patients will be targeted during “late summer” through the JDRF grant awarded to Washington University School of Medicine at St. Louis.

“SGLT inhibitors are improving outcomes in glucose control, heart disease, and kidney disease in non-type 1 diabetes populations, but are rarely used in type 1 diabetes because they increase the risk of DKA,” JDRF Associate Director of Research Jonathan Rosen said. “Development of ketone monitoring technologies like Biosense are a critical part of the strategy to enable safe, effective use of SGLT inhibitors in type 1 diabetes.”

Filed Under: Big Data, Business/Financial News, Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Funding Roundup, Patient Monitoring Tagged With: Juvenile Diabetes Research Foundation (JDRF), Readout Health

IN CASE YOU MISSED IT

  • Dexcom updates CGM receiver recall that led to serious adverse events
  • Abbott reports momentum with Libre CGM business as new dual sensor will ‘accelerate’ growth
  • Johnson & Johnson wins FDA priority review for drug delivery system
  • Glucose monitoring company LifeScan files chapter 11 to reduce debt
  • Medtronic enrolls first patient in study for Onyx liquid embolic system

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS